0.07 in our Hispanic-Caucasian sample and in Wong et al. In the HapMap Caucasian sample, this marker had a minor allele frequency of 0.1. For rs1880916, Wong et al. found a minor allele frequency of 0.12, compared to 0.17 in our sample, whereas the minor allele frequency was 0.2 in the HapMap Caucasian sample. These data suggest that the samples in both studies are similar.
Several lines of evidence implicate the role of folate pathway in the aetiology of depression. These include evidence that folic acid has shown promise as an adjuvant in complimenting antidepressant treatment, and the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene has been associated with depression. 1 Further, genome scans for depression, including early-onset depression, indicate linkage to 1p36.2, 2, 3 the location of the MTHFR gene. To investigate the role of the MTHFR gene in early-onset depression, we tested a functional polymorphism, C677T, as a risk factor in a large Hungarian sample of 583 families with children diagnosed with a mood disorder before the age of 15.
MTHFR is an enzyme involved in the metabolism of folic acid, by catalysing the reduction of 5,10-methylenetetrahydrofolate to 5-methyl tetrahydrofolate. This reaction acts as a methyl donor in the conversion of homocysteine, a product formed during methylation reactions, to methionine. Methionine is a precursor for S-adenosyl methionine, an important enzyme in the catabolism of methylation reactions in the central nervous system. Impairment in the conversion of homocysteine into methionine results in an increase in homocysteine levels, which can be deleterious through the inhibition of methylation reactions if left to accumulate. 1 There is a common C677T functional variant in the MTHFR gene resulting in an amino-acid transition from alanine to valine. This change leads to a thermolabile version of MTHFR with reduced enzymatic activity. 4 There are a number of studies that suggest an association between the low-activity allele (677T) and major depression, however there are also a number of negative reports. 1 Recently, Lewis et al.
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performed an association in a large female population sample and found an association between the MTHFR 677T allele and an increase in self-reported depression symptoms. To complement their analysis, they performed a meta-analysis on all previous reports, finding a combined odds ratio of 1.36 for the 677T allele in depression, thus indicating that this genetic variant is a small but significant risk factor for depression. For this study, C677T (rs1801133) was genotyped in 583 nuclear families ascertained through a child or adolescent with a diagnostic and statistical manual of mental disorders IV diagnosis of a mood disorder (unipolar or bipolar) before 15 years of age (childhood-onset mood disorder). Families consisted of 717 affected children (583 probands and 134 affected siblings). The recruitment and assessment of this sample has been described previously. 6 Genotyping was performed using the TaqMan 5 0 nuclease assay (Applied Biosystems, Foster City, CA, USA) (ABI probe ID, C_1202883_20). Transmission disequilibrium test analysis was performed using TDT phase. 7 Power calculations were permutated by the Quanto program (http://hydra.usc.edu/gxe). The minor allele frequency for this marker was 0.35 in this sample, which is consistent with previous studies and no deviation from the Hardy-Weinberg equilibrium was observed.
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No significant association was observed between childhood-onset mood disorder and the 677T allele (T 224: NT 246: w 2 = 1.03 P = 0.31) despite this sample having 85% power to detect the odds ratio of 1.36 obtained from the recent meta-analysis. 5 Thus, the results of this study fail to support the conclusion of the recent meta-analysis.
Inconsistencies in the outcome of investigations into the association between the 677T allele and depression could be attributed to the indirect nature of the pathological mechanism of this polymorphism. The 677T allele has been found to be associated with an increase in homocysteine and a decrease in folate, but both within the normal range. However, under sub-optimum folate status, the 677T allele is associated with increased plasma homocysteine 8 and global hypomethylation, 9 suggesting the existence of a gene Â nutrient interaction.
Elevated homocysteine levels have been associated with a wide range of phenotypes including dementia, arteriosclerosis, cardiovasculature disease, cognitive impairment, as well as depression. Interestingly, many of these phenotypes are also associated with the 677T allele. 10 Furthermore, extensive hypomethylation, which is probably a consequence of elevated homocysteine levels, could have diverse implications through the random expression of previously quiescent genes, and whether or not a change in methylation status contributes to psychopathology may depend on individual genetic architecture.
Elevated maternal levels of homocysteine during pregnancy are associated with premature delivery, pre-eclampsia and placental damage that may influence oxygen delivery to the fetus, risk factors indicated in a number of neuropsychiatric disorders. Further, a recent report suggested that maternal homozygosity of the T allele may be associated with an increase in imprinting defects in their offspring. 11 Thus, we tested for an excess of homozygous 677T mothers in our sample by comparing the genotype and allele frequencies of mothers and fathers. We found no significant difference between these two groups.
While it is evident that the 677T allele does not confer risk to the development of childhood-onset mood disorder in this sample, the presence of an interaction between folate status and C677T genotype may explain the previous inconsistent findings in the literature regarding depression. Consequently, certain studies may have an enrichment of depressed patients who are more vulnerable to folate changes, biasing the association results in specific populations. Another consideration is the possibility that excess homocysteine is contributing to depression related to vascular dysfunction in older populations. 12 To conclude, further exploration of this polymorphism and the interaction with folate status, as well as other variables, is required in depressed patient populations. However, the results of this study infer that the MTHFR genotype is unlikely to be a considerable risk factor for the development of childhood-onset mood disorder. 
